COPD

February 17, 2016February 18, 2016

Graphic Cigarette Warnings Seen to Trigger Decision-Making Brain Areas

COPD, Lung Cancer, News

Researchers with Georgetown University Medical Center and Truth Initiative recently reported that graphic anti-smoking images on cigarette packs produced brain activity in areas involved in memory, emotion, and decision-making, and may ... Read more

February 12, 2016February 18, 2016

COPD May Cause Structural Brain Changes Related to Fear, Pain, Breathlessness

COPD, News

A recent study revealed that patients with chronic obstructive pulmonary disease (COPD) exhibit gray matter decreases in areas of the brain that process breathlessness, fear, and sensitivity to pain. The ... Read more

February 10, 2016February 10, 2016

Lung Function in COPD Patients Shows Promise With STIOLTO RESPIMAT Inhalation Spray

COPD, News

Boehringer Ingelheim Pharmaceuticals announced the publication of promising new data regarding its inhalation spray, STIOLTO RESPIMAT, in the improvement of lung function when compared to therapy with an European formulation combining ... Read more

February 5, 2016May 13, 2016

New Inhaled Asthma Treatment, SPIRIVA RESPIMAT, Now Available in U.S.

Asthma, COPD, News

Boehringer Ingelheim Pharmaceuticals recently announced that SPIRIVA RESPIMAT, a new inhaled medicine for maintenance treatment of asthma, is now available by prescription in U.S. pharmacies for adults and adolescents. The U.S. Food ... Read more

February 4, 2016May 12, 2016

European Clinical Trial Enrolling Patients for COPD Treatment

COPD, News

Pulmatrix Inc., a clinical stage biopharma dedicated to the development of inhaled therapies to address serious pulmonary diseases, recently announced that its European pilot bioequivalence study on PUR0200 for the ... Read more

February 2, 2016February 3, 2016

FDA Approves IND Application for Multidrug-Resistant Bacterial Infections

Bronchiectasis, COPD, Cystic Fibrosis, Emphysema, News, Pneumonia

Matinas BioPharma Holdings recently announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application, and the company can now begin a Phase 1 clinical trial to ... Read more

January 28, 2016January 28, 2016

UC San Diego Researchers Develop Novel Detection Method for Antibiotics Resistance

Bronchiectasis, COPD, Cystic Fibrosis, News, Pneumonia

A recent article by UC San Diego researchers, published in the journal EBioMedicine, reported the development of a novel, rapid and efficient technique able to determine whether bacteria are resistant to ... Read more

January 27, 2016January 27, 2016

Study Shows COPD Pulmonary Function Improved With Stem Cell Therapy

COPD, News

A doctor at the Lung Institute recently released a report outlining a study showing that stem cell therapy in patients with lung diseases can improve patients’ quality of life along with pulmonary function. The article ... Read more

January 26, 2016January 26, 2016

New Respiratory Therapy’s Clinical Program Getting European Patent Protection

COPD, Idiopathic Pulmonary Fibrosis, News, Pulmonary Hypertension

Bellerophon Therapeutics, Inc., a clinical-stage biotherapeutics company specializing in the development of drugs and devices for cardiopulmonary conditions, recently announced that the European Patent Office has issued a Notice of Intention ... Read more

January 25, 2016May 12, 2016

Upcoming American Thoracic Society Conference on Pulmonary Diseases

Asthma, COPD, Idiopathic Pulmonary Fibrosis, Lung Cancer, News, Pulmonary Hypertension

The American Thoracic Society (ATS) is inviting all those who are interested to its 2016 International Conference at the Moscone Center in San Francisco, on topics such as pulmonary, critical ... Read more